New Pill Blocks COVID After Exposure in 2,000-Person Trial

A daily pill taken after COVID exposure prevented symptoms in 97% of people who took it, offering the first proven protection for vulnerable populations living with infected household members.

The drug could soon reach U.

patients after Japan and Singapore already approved it.